Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Windlas Biotech
Dehradun, Uttarakhand, India
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Other
01
Overview
Windlas Biotech is a leading Indian CDMO pharma company with several programs in chronic and sub-chronic areas (notably diabetes, cardiovascular, respiratory, and neuropsychiatric), active in late-stage clinical trials and commercial manufacturing, including 6 clinical trials and Phase 3 development for a combination allergy drug[8][4][1].
- Therapeutic areas
- ImmunologyEndocrinologyInfectious DiseasesGastroenterologyPulmonologyCardiovascularNeurology
- Modalities
- Small moleculePeptidesBiologicCombination product
- Industry
- Biotech
02
Partnerships
Cipla (South Africa commercial partner)
Beyond the preview
Go deeper on Windlas Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Windlas Biotech.